Literature DB >> 27385595

Cell sources for in vitro human liver cell culture models.

Katrin Zeilinger1, Nora Freyer2, Georg Damm3, Daniel Seehofer3, Fanny Knöspel2.   

Abstract

In vitro liver cell culture models are gaining increasing importance in pharmacological and toxicological research. The source of cells used is critical for the relevance and the predictive value of such models. Primary human hepatocytes (PHH) are currently considered to be the gold standard for hepatic in vitro culture models, since they directly reflect the specific metabolism and functionality of the human liver; however, the scarcity and difficult logistics of PHH have driven researchers to explore alternative cell sources, including liver cell lines and pluripotent stem cells. Liver cell lines generated from hepatomas or by genetic manipulation are widely used due to their good availability, but they are generally altered in certain metabolic functions. For the past few years, adult and pluripotent stem cells have been attracting increasing attention, due their ability to proliferate and to differentiate into hepatocyte-like cells in vitro However, controlling the differentiation of these cells is still a challenge. This review gives an overview of the major human cell sources under investigation for in vitro liver cell culture models, including primary human liver cells, liver cell lines, and stem cells. The promises and challenges of different cell types are discussed with a focus on the complex 2D and 3D culture approaches under investigation for improving liver cell functionality in vitro Finally, the specific application options of individual cell sources in pharmacological research or disease modeling are described.
© 2016 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  3D culture technologies; Liver cell culture; in vitro models; liver cell lines; primary human hepatocytes; stem cells

Mesh:

Year:  2016        PMID: 27385595      PMCID: PMC4999620          DOI: 10.1177/1535370216657448

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  150 in total

Review 1.  Involvement of cell junctions in hepatocyte culture functionality.

Authors:  Mathieu Vinken; Peggy Papeleu; Sarah Snykers; Evelien De Rop; Tom Henkens; James Kevin Chipman; Vera Rogiers; Tamara Vanhaecke
Journal:  Crit Rev Toxicol       Date:  2006-04       Impact factor: 5.635

2.  Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.

Authors:  Yuchao Xie; Mitchell R McGill; Kenneth Dorko; Sean C Kumer; Timothy M Schmitt; Jameson Forster; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2014-06-03       Impact factor: 4.219

3.  Human primary cultured hepatic stellate cells can be cryopreserved.

Authors:  Anna Nakamura; Takato Ueno; Yumihiko Yagi; Koji Okuda; Toshiro Ogata; Toru Nakamura; Takuji Torimura; Hideki Iwamoto; Sivakumar Ramadoss; Michio Sata; Victor Tsutsumi; Kaori Yasuda; Yumi Tomiyasu; Kenichi Obayashi; Kosuke Tashiro; Satoru Kuhara
Journal:  Med Mol Morphol       Date:  2010-08-04       Impact factor: 2.309

4.  Suppression of hepatocyte CYP1A2 expression by Kupffer cells via AhR pathway: the central role of proinflammatory cytokines.

Authors:  Rongqian Wu; Xiaoxuan Cui; Weifeng Dong; Mian Zhou; H Hank Simms; Ping Wang
Journal:  Int J Mol Med       Date:  2006-08       Impact factor: 4.101

5.  Tissue collection, transport and isolation procedures required to optimize human hepatocyte isolation from waste liver surgical resections. A multilaboratory study.

Authors:  Lysiane Richert; Eliane Alexandre; Tom Lloyd; Samantha Orr; Catherine Viollon-Abadie; Rakhee Patel; Shaun Kingston; David Berry; Ashley Dennison; Bruno Heyd; Georges Mantion; Daniel Jaeck
Journal:  Liver Int       Date:  2004-08       Impact factor: 5.828

6.  Stiffness of hyaluronic acid gels containing liver extracellular matrix supports human hepatocyte function and alters cell morphology.

Authors:  Daniel B Deegan; Cynthia Zimmerman; Aleksander Skardal; Anthony Atala; Thomas D Shupe
Journal:  J Mech Behav Biomed Mater       Date:  2015-10-30

7.  Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.

Authors:  David Campard; Philippe A Lysy; Mustapha Najimi; Etienne Marc Sokal
Journal:  Gastroenterology       Date:  2007-12-23       Impact factor: 22.682

8.  Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells.

Authors:  Richard Siller; Sebastian Greenhough; Elena Naumovska; Gareth J Sullivan
Journal:  Stem Cell Reports       Date:  2015-04-30       Impact factor: 7.765

9.  Accurate prediction of drug-induced liver injury using stem cell-derived populations.

Authors:  Dagmara Szkolnicka; Sarah L Farnworth; Baltasar Lucendo-Villarin; Christopher Storck; Wenli Zhou; John P Iredale; Oliver Flint; David C Hay
Journal:  Stem Cells Transl Med       Date:  2013-12-27       Impact factor: 6.940

10.  Human hepatic stem cells from fetal and postnatal donors.

Authors:  Eva Schmelzer; Lili Zhang; Andrew Bruce; Eliane Wauthier; John Ludlow; Hsin-lei Yao; Nicholas Moss; Alaa Melhem; Randall McClelland; William Turner; Michael Kulik; Sonya Sherwood; Tommi Tallheden; Nancy Cheng; Mark E Furth; Lola M Reid
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  42 in total

1.  Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.

Authors:  Rie Ouchi; Shodai Togo; Masaki Kimura; Tadahiro Shinozawa; Masaru Koido; Hiroyuki Koike; Wendy Thompson; Rebekah A Karns; Christopher N Mayhew; Patrick S McGrath; Heather A McCauley; Ran-Ran Zhang; Kyle Lewis; Shoyo Hakozaki; Autumn Ferguson; Norikazu Saiki; Yosuke Yoneyama; Ichiro Takeuchi; Yo Mabuchi; Chihiro Akazawa; Hiroshi Y Yoshikawa; James M Wells; Takanori Takebe
Journal:  Cell Metab       Date:  2019-05-30       Impact factor: 27.287

Review 2.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

3.  New and effective method to develop primary hepatocytes from liver cancer patients.

Authors:  Jia-Yan Li; Li-Li Wang; Jing Fan; Du-Xian Liu; Jian-Bo Han; Yu-Feng Zhang; Dan-Dan Yin; Yong-Xiang Yi
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-26

4.  A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy.

Authors:  Yuri Efremov; Anastasia Ermolaeva; Georgiy Vladimirov; Susanna Gordleeva; Andrey Svistunov; Alexey Zaikin; Peter Timashev
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

5.  Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery.

Authors:  Jui-Tung Liu; Mary Paige Lamprecht; Stephen A Duncan
Journal:  J Vis Exp       Date:  2018-05-19       Impact factor: 1.355

6.  Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity.

Authors:  Sandeep Sundriyal; Patty B Chen; Alexandra S Lubin; Gregor A Lueg; Fengling Li; Andrew J P White; Nicholas A Malmquist; Masoud Vedadi; Artur Scherf; Matthew J Fuchter
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

Review 7.  Liver cell therapy: is this the end of the beginning?

Authors:  Salamah M Alwahsh; Hassan Rashidi; David C Hay
Journal:  Cell Mol Life Sci       Date:  2017-11-27       Impact factor: 9.261

8.  Glutathione-related inflammatory signature in hepatocytes differentiated from the progenitor mesenchymal stem cells.

Authors:  Abdolamir Allameh; Hamid Reza Ahmadi-Ashtiani; Narges Maleki
Journal:  Heliyon       Date:  2020-06-08

Review 9.  Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development.

Authors:  Xiying Lin; Jiayu Tang; Yan-Ru Lou
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-30

10.  Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals?

Authors:  Monika Waldherr; Miroslav Mišík; Franziska Ferk; Jana Tomc; Bojana Žegura; Metka Filipič; Wolfgang Mikulits; Sören Mai; Oskar Haas; Wolfgang W Huber; Elisabeth Haslinger; Siegfried Knasmüller
Journal:  Arch Toxicol       Date:  2017-12-07       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.